| Name | Title | Contact Details |
|---|
Gladden Longevity is a comprehensive concierge medical program dedicated to health optimization and performance, with a focus on age reversal. They offer wellness and fitness services, neurocognitive testing, body composition analysis, cardiovascular p...
himagine solutions inc. is a leading healthcare outsourcing solutions provider with the largest team of inpatient and outpatient coders in the U.S. Our professional HIM outsourcing services include basic staff augmentation as well as more strategic managed coding solutions including full department outsourcing through our Enterprise HIM offering to support more than 250 healthcare providers across the U.S. With our significant and growing base of HIM Subject Matter Experts we provide support for all of our offerings to ensure our client partners receive the most value from our services.
Neuralstem is a dual platform regenerative medicine company. The company`s technology enables the production of regionally specific, physiologically relevant neural stem cells for therapeutic use for the treatment of central nervous system (CNS) diseases and has enabled the discovery of a library of patented small molecule neurogenic compounds to treat psychological and cognitive disorders. Neuralstem`s small molecule drug discovery program screens human neural stem cell lines for compounds that may stimulate neurogenesis in the brain, possibly reversing pathologies associated with certain CNS conditions. The company`s lead compound, NSI-189, has completed FDA Phase Ia and Ib safety trials for the treatment of major depressive disorder (MDD). Neuralstem is expecting to launch a Phase II study for MDD in 2015. Neuralstem`s first stem cell therapy product, NSI-566, a spinal cord-derived neural stem cell line, is in ongoing clinical trials to treat amyotrophic lateral sclerosis (ALS, or Lou Gehrig`s disease), for which it has received orphan status designation by the FDA. Dosing in a phase IIa trial was completed in July, 2014. The next trial is anticipated to commence in 2015. In addition to ALS, the company is conducting an NSI-566 Phase I trial in chronic spinal cord injury, with NSI-566 clinical development also underway to treat ischemic
SwedishAmerican Health System is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. SwedishAmerican Health System is based in Rockford, IL. You can find more information on SwedishAmerican Health System at www.swedishamerican.org
Chandler Place is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.